BioCentury
ARTICLE | Clinical News

PRT062070: Phase I/II started

October 21, 2013 7:00 AM UTC

Portola began an open-label Phase I/II trial of PRT2070. The Phase I portion will evaluate escalating doses of PTR2070 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small ...